S. Saks

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Bruce A. Feinberg, Razelle Kurzrock, Moshe Talpaz et al. · Journal of Clinical Oncology · 1988 · 222 citations

Immunology, Rtnf-alpha Induced Changes, Pathology +16

Phase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell Lymphoma

Edward H. Kaplan, Steven T. Rosen, D. B. Norris et al. · JNCI Journal of the National Cancer Institute · 1990 · 169 citations

Immunology, Phase Ii Study, Dermatology +17

Therapy of chronic myelogenous leukemia with recombinant interferon- gamma

Razelle Kurzrock, Moshe Talpaz, H Kantarjian et al. · Blood · 1987 · 88 citations · Full text

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer.

James L. Abbruzzese, Bernard Levin, Jaffer A. Ajani et al. · PubMed · 1989 · 66 citations

Advanced Gastrointestinal Cancer, Gastrointestinal Oncology, Recombinant Human Gamma-interferon +12

Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.

David M. Aboulafia, Steven A. Miles, S. Saks et al. · PubMed · 1989 · 53 citations

Primary Immunodeficiency, Tumor Necrosis Factor, Drug Infusion +12